Augmedix, Inc. provided revenue guidance for the fourth quarter of 2022. Given the strength of its recent bookings and the health of its current backlog, the company expects revenue in the fourth quarter of 2022 to be approximately $8.5 million to $8.6 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.175 USD | +1.29% | +3.06% | -79.83% |
May. 14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
May. 14 | B. Riley Adjusts Price Target on Augmedix to $3 From $5.50, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.83% | 56.54M | |
+15.76% | 70.77B | |
+6.09% | 17.14B | |
+12.66% | 13.82B | |
+19.72% | 13.49B | |
+15.69% | 10.06B | |
-18.67% | 7.24B | |
-2.25% | 6.18B | |
+3.42% | 5.26B | |
+0.29% | 5.03B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022